SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ReWalk Robotics Ltd. - RWLK

NEW YORK, Oct. 6, 2016

The investigation concerns whether ReWalk and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

[Click here to join a class action]

On or about September 17, 2014, ReWalk announced the closing of its initial public offering ("IPO") of 3,450,000 ordinary shares to the public, through which the Company raised approximately $41.4 million.  The IPO's registration statement stated that the U.S. Food and Drug Administration ("FDA") had classified ReWalk as subject to special controls, which included compliance with medical device consensus standards, performance of a post-market surveillance clinical study demonstrating a reasonable assurance of safety and effectiveness in urban terrain, and a training program, among other things.  In September 2015, ReWalk received a Warning Letter from the FDA, outlining ReWalk's substantial failures to propose and commence an adequate post-market surveillance plan. 

On February 25, 2016, ReWalk disclosed receipt of the FDA's warning letter.  On this news, the Company's share price fell $1.24, or 10.64%, to close at $10.41 on February 25, 2016. 

On May 10, 2016, ReWalk revealed that at the time of the IPO, the Company had been unable to comply with the FDA's special controls due to inadequate staffing.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com